Investing.com - Viatris reported on Monday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Viatris announced earnings per share of $-0.86 on revenue of $4.43B. Analysts polled by Investing.com anticipated EPS of $0.799 on revenue of $4.2B.
Viatris shares are down 24.87% from the beginning of the year and are trading at $14.08 , down-from-52-week-high.They are under-performing the S&P 500 which is up 12.69% from the start of the year.
Viatris follows other major Healthcare sector earnings this month
Viatris's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Pfizer had beat expectations on May 4 with first quarter EPS of $0.93 on revenue of $14.58B, compared to forecast for EPS of $0.7759 on revenue of $13.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar